Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
批准号:
6433073
负责人:
VICTOR MARQUEZ
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
核苷和核苷酸本质上是由糖段和非杂环碱基组成的柔性分子。糖块的构象灵活性可以用伪旋转相位角(P)来描述,它考虑了糖环的五个扭转角的贡献。P的首选范围确定了两个主要结构域,以北构象(P = 0)和南构象(P = 180)为中心,它们在溶液中迅速平衡。解释核苷和核苷酸的结构-活性相关性的主要障碍之一是这种高水平的灵活性。在过去的几年里,我们设计了一系列新的核苷,其中柔性糖部分被刚性碳环(即双环[3.1.0]己烷)取代,模仿传统核苷的北或南构象。我们的第一个目标是系统地探索一系列核苷/核苷酸结合酶与一系列构象刚性的北底物和南底物,以了解首选的结合模式。我们的第二个目标是构建包含这些固定单元的修饰核酸,分别加强或破坏与南构象和北构象相关的典型B-或a - dna构象。对于我们的第一个目标,我们已经证明了激酶(疱疹胸苷激酶和细胞脱氧胞苷激酶)对南构象的明显偏好。另一方面,聚合酶(疱疹DNA聚合酶和艾滋病毒逆转录酶)几乎完全倾向于北方构象。相对于我们的第二个目标,我们已经合成了一系列短的(13米)和中等大小的(27米)寡脱氧核苷酸(odn)含有刚性的南基和北基位点以及一个柔性的(环戊烷)参考来研究HhaI DNA(胞嘧啶C5)-甲基转移酶的碱基翻转机制。在此过程中,我们发现了该酶最有效的ODN抑制剂之一(IC50 = 14 nM),其基本位点锁定在南构象中。所需的南北磷酰胺的合成以及相应的odn的合成都有了很大的改进。建立在北双环[3.1.0]己烷模板上的新型5-取代硬膜嘧啶碳环核苷被证明具有极有效的抗疱疹(例如,5-溴)和抗水痘带状疱疹(例如,5-溴酰)活性。这些化合物以及胸腺嘧啶类似物正在研究它们在癌症基因治疗中的潜在用途。为了满足对大量的Northbicyclo[3.1.0]己烷模板的需求,一种新的碳插入反应在一步中构建了整个双环结构。这个碳插入反应也正在被研究,以开发对映的南双环[3.1.0]己烷模板。艾滋病题目:抗疱疹活性辅助治疗艾滋病癌症题目:基因治疗,DNA甲基转移酶。
英文摘要
Nucleosides and nucleotides are inherently flexible molecules comprised of a sugar moiety and aheterocyclic base. The conformational flexibility of the sugar moiety can be described in terms ofthe pseudorotational phase angle (P), which takes into accoung the contribution of the five torsionangles of the sugar ring. The preferred ranges of P define two main domains centered around aNorth conformation (P = 0) and a South conformation (P = 180) which equilibrate rapidly in solution. One of the main obstacles in interpreting structure-activity correlations in nucleosides and nucleotides is this high level of flexibility. For the past several years we have designed a series of novel nucleosides where the flexible sugar moiety has been replaced by a rigid carbocyclic ring (i.e., bicyclo[3.1.0]hexane) that mimics either the North or South conformation of conventional nucleosides. Our first objective is to systematically probe a series of nucleoside/nucleotide binding enzymes with sets of conformationally rigid North and South substrates to learn about the preferred mode of binding. Our second objective is to construct modified nucleic acids that incorporate some of these fixed units to either reinforce or disrupt the typical B- or A-DNAconformations associated with South and North conformations, respectively. Towards our firstobjective, we have demonstrated the clear preference of kinases (herpes thymidine kinase andcellular deoxycytidine kinase) for the South conformation. On the other hand, the polymerases(herpes DNA polymerase and HIV reverse transcriptase) show an almost exclusively preference for the North conformers. Relative to our second goal, we have synthesized a series of short (13 mers) and mid-size (27-mers) oligodeoxynucleotides (ODNs) containing rigid South and North abasic sites as well as a flexible (cyclopentane) reference to study the mechanism of base flipping of HhaI DNA (cytosine C5)-methyl transferase. In the process, we have discovered one of the most potent ODN inhibitors of this enzyme (IC50 = 14 nM) containing the abasic site locked in the South conformation. The syntheses of the requisite North and South phosphoramidites aswell as the syntheses of the corresponding ODNs were vastly improved. Novel 5-substituteduracil carbocyclic nucleosides built on a North bicyclo[3.1.0]hexane template were shown to haveextremely potent anti-herpes (e.g., the 5-bromo) and anti-varicela zoster (e.g., 5-bromovinyl)activity. These compounds, along with the thymidine analogue are being investigated for theirpotential use in the gene therapy of cancer. The increase demand for larger quantities of the Northbicyclo[3.1.0]hexane template has been met by a novel carbene insertion reaction where the entirebicyclic structure is constructed in one step. This carbene insertion reaction is also beinginvestigated to develop the antipodal South bicyclo[3.1.0]hexane template. AIDS title: Antiherpes activity for the adjuvant treatment of AIDS CANCER title: Gene therapy, DNA methyltransferase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
-
批准号:6289175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs
-
批准号:6433074
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:6433072
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
COMPUTER-AIDED DRUG DESIGN MINICORE FACILITY PROJECT
-
批准号:6424474
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:7048150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Carbocyclic Nucleoside Isosteres as Potential Antitumor
-
批准号:7290501
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Enzyme Inhibitors as Potential Anticancer and Antiviral
-
批准号:6761653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Enzyme Inhibitors as Potential Anticancer and Antiviral
-
批准号:7337936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:6558980
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Carbocyclic Nucleoside Isosteres as Potential Antitumor
-
批准号:6950178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
COMPUTER-AIDED DRUG DESIGN MINICORE FACILITY PROJECT
-
批准号:6424381
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:7290499
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Carbocyclic Nucleoside Isosteres as Potential Antitumor
-
批准号:6761652
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:7592560
-
项目类别:
-
资助金额:$38.13万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Enzyme Inhibitors as Potential Anticancer and Antiviral
-
批准号:7048154
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Dideoxynucleosides as Potential Anti-AIDS Drugs
-
批准号:7337934
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Carbocyclic Nucleoside Isosteres as Potential Antitumor
-
批准号:7337935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Computer-Aided Drug Design (CADD) Group Project: HIV Int
-
批准号:6763742
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
Enzyme Inhibitors as Potential Anticancer and Antiviral
-
批准号:7290502
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
STRUCTURAL ANALYSIS OF NUCLEIC ACID COMPONENTS BY NMR
-
批准号:6424703
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:VICTOR MARQUEZ
-
依托单位:
海外基金